Consistently, with the strong interaction of the RONC-aH2 antibodies with melanoma MTP, the CD28-OX-40-HER2-specific CAR-T/NK cells were able to effectively lyse the HER2-positive melanoma cell line (Figure 9). Here, ERBB2 is linked to melanoma.